Spoofing Vulnerability in IBM Security ReaQta EDR Product
CVE-2023-33861

6.5MEDIUM

Key Information:

Vendor

IBM
Status
Security Reaqta Edr
Vendor
CVE Published:
20 May 2025

What is CVE-2023-33861?

A spoofing vulnerability in IBM Security ReaQta EDR version 3.12 allows attackers to potentially impersonate a legitimate entity. This interference targets the communication channel between the host and client, compromising the integrity of the data exchanged. Organizations using the affected version may be at risk of unauthorized access and data breaches if this vulnerability is exploited. Immediate action is advised to mitigate potential attacks.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Security ReaQta EDR 3.12

References

https://www.ibm.com/support/pages/node/7233972
vendor-advisory

CVSS V3.1

Score:
6.5
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.